Oh, you have read this information on the company before? I've never posted that on this board before but since you are already following the story so closely, my apologies to you.
"BPUR Why repeat info from last June???"
Last June was less than 90 days ago. Does that seem "long ago" to you?
"What news do you expect tomorrow that requires such an intense repeat of old news?"
I expect to get an answer from the FDA on whether or not the Navy can proceed with their trauma trial. I don't understand why you would ask me if I expect it tomorrow? I expect it to be very soon and I have no clue if it will be a "yes" or a "no" but I'm hoping it will be a "yes" because our soldiers need whatever medical advantages that are available to them.
"The story you quoted reports Jahr's work, and says, "Jahr has served as the principal investigator on one additional Biopure study and owns Biopure stock."
It is indeed significant to see the fact that he owns stock. Would he have bought the stock if he believed that HBOC-201 did not have a positive benefit to risk profile? I doubt it. Thank you for emphasizing this point as it is indeed suggestively noteworthy.
"Why is this new?"
Again, this is most likely new information to you. June was very recent and I have not noticed any of this information posted here before.
So, what's up with the cynicism?